{"id":885,"date":"2020-06-24T14:03:39","date_gmt":"2020-06-24T04:03:39","guid":{"rendered":"https:\/\/test.onephenix.com\/blog\/?p=885"},"modified":"2020-06-24T14:03:39","modified_gmt":"2020-06-24T04:03:39","slug":"asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1","status":"publish","type":"post","link":"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/","title":{"rendered":"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1"},"content":{"rendered":"\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/test.onephenix.com\/blog\/wp-content\/uploads\/2020\/06\/blood-sample-for-covid-19-2021-08-28-15-43-01-utc-min-1024x465.jpg\" alt=\"\" class=\"wp-image-1876\"\/><\/figure>\n\n\n\n<p><em>ResApp Health Sign Software Licensing Agreement with Phenix Health<\/em><\/p>\n\n\n\n<p>On 16 June 2020, ResApp and Phenix Health signed a licensing deal for employing ResAppDx-EU in telehealth smartphone application of Phenix. This agreement is a non-exclusive commercial software licensing agreement for two years. With this deal, ResAppDx-EU can be applied in the telehealth smartphone applications by Phenix Health in Australia starting 1 July.<\/p>\n\n\n\n<p>For the full article please visit: <a href=\"https:\/\/kalkinemedia.com\/au\/healthcare\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\">https:\/\/kalkinemedia.com\/au\/healthcare\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ResApp Health Sign Software Licensing Agreement with Phenix Health On 16 June 2020, ResApp and Phenix Health signed a licensing deal for employing ResAppDx-EU in telehealth smartphone application of Phenix. This agreement is a non-exclusive commercial software licensing agreement for two years. With this deal, ResAppDx-EU can be applied in the telehealth smartphone applications by&#8230;<\/p>\n","protected":false},"author":5,"featured_media":1876,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32],"tags":[98,106,117],"class_list":["post-885","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-press-release","tag-phenixhealth","tag-resapp","tag-telehealth"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.9.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1 - Phenix Health<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1 - Phenix Health\" \/>\n<meta property=\"og:description\" content=\"ResApp Health Sign Software Licensing Agreement with Phenix Health On 16 June 2020, ResApp and Phenix Health signed a licensing deal for employing ResAppDx-EU in telehealth smartphone application of Phenix. This agreement is a non-exclusive commercial software licensing agreement for two years. With this deal, ResAppDx-EU can be applied in the telehealth smartphone applications by...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/\" \/>\n<meta property=\"og:site_name\" content=\"Phenix Health\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-24T04:03:39+00:00\" \/>\n<meta name=\"author\" content=\"Gillian Alexis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gillian Alexis\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/\",\"url\":\"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/\",\"name\":\"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1 - Phenix Health\",\"isPartOf\":{\"@id\":\"https:\/\/test.onephenix.com\/blog\/#website\"},\"datePublished\":\"2020-06-24T04:03:39+00:00\",\"dateModified\":\"2020-06-24T04:03:39+00:00\",\"author\":{\"@id\":\"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868\"},\"breadcrumb\":{\"@id\":\"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/#breadcrumb\"},\"inLanguage\":\"en-AU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/test.onephenix.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/#website\",\"url\":\"https:\/\/test.onephenix.com\/blog\/\",\"name\":\"Phenix Health\",\"description\":\"Online Doctor Australia | Telehealth Doctor | Phenix Health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/test.onephenix.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-AU\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868\",\"name\":\"Gillian Alexis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-AU\",\"@id\":\"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g\",\"caption\":\"Gillian Alexis\"},\"url\":\"https:\/\/test.onephenix.com\/blog\/author\/q7ewsfmf4x\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1 - Phenix Health","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/","og_locale":"en_US","og_type":"article","og_title":"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1 - Phenix Health","og_description":"ResApp Health Sign Software Licensing Agreement with Phenix Health On 16 June 2020, ResApp and Phenix Health signed a licensing deal for employing ResAppDx-EU in telehealth smartphone application of Phenix. This agreement is a non-exclusive commercial software licensing agreement for two years. With this deal, ResAppDx-EU can be applied in the telehealth smartphone applications by...","og_url":"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/","og_site_name":"Phenix Health","article_published_time":"2020-06-24T04:03:39+00:00","author":"Gillian Alexis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Gillian Alexis"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/","url":"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/","name":"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1 - Phenix Health","isPartOf":{"@id":"https:\/\/test.onephenix.com\/blog\/#website"},"datePublished":"2020-06-24T04:03:39+00:00","dateModified":"2020-06-24T04:03:39+00:00","author":{"@id":"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868"},"breadcrumb":{"@id":"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/#breadcrumb"},"inLanguage":"en-AU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/test.onephenix.com\/blog\/asx-listed-digital-healthcare-stock-amid-covid-19-a-look-at-rap-hrd-td1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/test.onephenix.com\/blog\/"},{"@type":"ListItem","position":2,"name":"ASX-listed Digital Healthcare Stock Amid COVID-19: A Look At RAP, HRD, TD1"}]},{"@type":"WebSite","@id":"https:\/\/test.onephenix.com\/blog\/#website","url":"https:\/\/test.onephenix.com\/blog\/","name":"Phenix Health","description":"Online Doctor Australia | Telehealth Doctor | Phenix Health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/test.onephenix.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-AU"},{"@type":"Person","@id":"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/200244242cc0ef8d220cb8b7c2aee868","name":"Gillian Alexis","image":{"@type":"ImageObject","inLanguage":"en-AU","@id":"https:\/\/test.onephenix.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ff8e52854b99dc898785ecf20f891c5e051e0f98d52a5228ff8d3ce2a7fe39b?s=96&d=mm&r=g","caption":"Gillian Alexis"},"url":"https:\/\/test.onephenix.com\/blog\/author\/q7ewsfmf4x\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"Gillian Alexis","author_link":"https:\/\/test.onephenix.com\/blog\/author\/q7ewsfmf4x\/"},"_links":{"self":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/posts\/885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/comments?post=885"}],"version-history":[{"count":0,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/posts\/885\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/media?parent=885"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/categories?post=885"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/test.onephenix.com\/blog\/wp-json\/wp\/v2\/tags?post=885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}